Wellcome responds to first healthy babies born in the UK thanks to mitochondrial donation

Beth Thompson, Executive Director for Policy & Partnerships at Wellcome, responds research published in The New England Journal of Medicine, showing eight healthy babies were born following mitochondrial donation IVF to reduce the transmission of mitochondrial DNA disease

2-minute read
2-minute read

Beth Thompson, Executive Director for Policy & Partnerships at Wellcome, said:

“This is a remarkable scientific achievement, which has been years in the making and we are overjoyed for the families of the eight children born so far.

“The pioneering work behind mitochondrial donation is a powerful example of how discovery research can change lives. The UK has led the way and has demonstrated the importance of science grounded in close and careful co-ordination between researchers, funders and regulators – and, very importantly, working closely with families affected.

“Wellcome has proudly supported this work since the earliest days, including advocating for legislation and licensing. As the science progresses, we will continue championing brave investment in science and for policy and regulation to keep pace. The success of this research should inspire us move forward on other updates, opening the way for further innovation. The groundwork for review of Human Fertilisation and Embryology Act, for example, has been done, it now needs to move forward. We must ensure the UK stays a world leader in life sciences.”